The EXCEL Trial: The Surgeons' Perspective.

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Left main stem disease is a critical condition requiring revascularization.
• Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are primary treatment options.
• Controversy exists regarding the comparative efficacy and safety of PCI versus CABG for left main stem disease.

Purpose of the Study:

• To critically review the methodology, results, and controversies of the EXCEL trial.
• To analyze other comparative studies on PCI versus CABG for left main stem disease.
• To discuss the role of the SYNTAX score in guiding revascularization decisions.

Main Methods:

• Review of existing clinical trials, including the EXCEL trial.
• Analysis of trial design, data reporting, and statistical interpretation.
• Evaluation of the clinical implications of study findings.

Main Results:

• The EXCEL trial's design and results have faced significant debate.
• Existing evidence comparing PCI and CABG for left main stem disease is complex and sometimes conflicting.
• The SYNTAX score aids in risk stratification for revascularization procedures.

Conclusions:

• Careful consideration of trial evidence, including controversies, is essential for left main stem disease management.
• Multidisciplinary team meetings are crucial for optimal patient selection and treatment planning.
• Informed decision-making by clinicians and patients requires a comprehensive understanding of available revascularization options.